(Q41283986)

29 September 2017

1 reference

title

Exploration of platinum-based dose-intensive chemotherapy strategies with amifostine (Ethyol). (English)

1 reference

29 September 2017

Schuchter LM

1

1 reference

29 September 2017

publication date

1 January 1996

1 reference

European Journal of Cancer

29 September 2017

published in

1 reference

29 September 2017

volume

32A Suppl 4

1 reference

29 September 2017

page(s)

S40-2

1 reference

Cysteine Protection against X Irradiation

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900316-4

7 January 2021

Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900316-4

7 January 2021

Biochemical modification of the toxicity and the anti-tumour effect of 5-fluorouracil and cis-platinum by WR-2721 in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900316-4

7 January 2021

Effects of the modulating agent WR2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulphate and diethyldithiocarbamate

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900316-4

7 January 2021

Phase I trials of WR-2721 and cis-platinum

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900316-4

7 January 2021

Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900316-4

7 January 2021

WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900316-4

7 January 2021

10.1016/S0959-8049(96)00316-4

Identifiers

DOI

1 reference

29 September 2017

1 reference